South Korea
Industry
BMI View: BMI's view on the liberalisation of South Korea's over-the-counter (OTC) sector is playing out as the government will allow the sale of OTC drugs in convenience stores. We...
2012-01-03Industry
BMI Core View: Non-healthcare companies, particularly technology firms, will increasingly enter the medical services sector. Companies see healthcare as a sustainable and expanding...
2011-12-07Industry
BMI View: South Korea's renewed commitment on stem cell research will allow it to become a key leader in this field of scientific research and development (R&D) in Asia, alongside...
2011-11-17Industry
BMI View: The free trade agreement (FTA) signed between South Korea and the US will benefit US pharmaceutical companies more than South Korean drugmakers as the FTA seeks to protect...
2011-10-19Industry
BMI View: We do not expect South Korea's new Minister of Health and Welfare, Rim Che-min to continue the pursuit of aggressive medicine price cuts, as he appears to be concerned about...
2011-10-12Industry
BMI View: South Korea's approval of a stem cell treatment highlights the country's gradual acceptance of the therapeutic approach. However, because such treatments are costly and are...
2011-07-08Industry
BMI View: Pressure from the public requesting the sales of over-the-counter (OTC) drugs in supermarkets and convenience stores in South Korea will be met in the longer term, despite...
2011-06-03Industry
BMI View: Telemedicine is increasing in popularity because it saves time for healthcare professionals and patients, particularly those in rural areas. It also reduces the cost of medical...
2011-05-13




